Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | MEDI1191 |
Trade Name | |
Synonyms | MEDI-1191|MEDI 1191 |
Drug Descriptions |
MEDI1191 is an encapsulated mRNA formulation of interleukin-12 subunit beta (IL12B) and interleukin-12 subunit alpha (IL12A), which activate the immune system and prevent tumor cell proliferation (PMID: 32817076). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | C160867 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Durvalumab + MEDI1191 | Durvalumab MEDI1191 | 0 | 1 |
MEDI1191 | MEDI1191 | 0 | 1 |